Literature DB >> 16453208

Colonoscopic findings of symptomatic patients aged 50 to 80 years suggest that work-up of tumour suspicious symptoms hardly reduces cancer-induced mortality.

Alain Schoepfer1, Urs A Marbet.   

Abstract

QUESTIONS UNDER STUDY: The risk of colorectal cancer (CRC) starts to increase at the age of 50 years in average persons without special risk factors. The significance of clinical symptoms and frequency of endoscopies done at this age are hitherto unknown. We do not know the stage of colorectal cancers nor the distribution of advanced neoplasms in symptomatic persons above 50 years. These data are of interest to validate the necessity of screening programmes, to define the target population and to interpret results of screening studies in asymptomatic people.
METHODS: Endoscopies of the colon performed from 1991 to 2000 in symptomatic patients aged 50 to 80 in the well-defined area of Uri were analysed retrospectively, focusing on symptoms leading to the endoscopy and the occurrence of neoplastic lesions.
RESULTS: Sixteen percent of the population at the age of 50-80 years had a colonoscopy for workup of symptoms. A CRC was found in 5.5% of all patients (83 of 1514 patients), in 12.3% of patients with tumour suspicious symptoms, but only in 0.3% of patients with unspecific pain. Stage of tumours was often advanced (82% T3/T4, 38% N1-3, 21% M1). In 2.6% of patients a colorectal cancer was found before the age of 60, mostly in men. Advanced lesions were more frequent in men, increasing with age.
CONCLUSIONS: A substantial part of the population above the age of 50 had an endoscopic workup of the colon for symptoms, what has to be considered when defining the target population and the necessary manpower of screening programmes. Tumour-suspicious symptoms were significant predictors for the presence of a CRC, but tumours were often already advanced. This underlines the importance to screen persons before developing symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 16453208     DOI: 2005/45/smw-11033

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  5 in total

Review 1.  Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review.

Authors:  Barbara-Ann Adelstein; Petra Macaskill; Siew F Chan; Peter H Katelaris; Les Irwig
Journal:  BMC Gastroenterol       Date:  2011-05-30       Impact factor: 3.067

2.  Clinicopathological features of colon polyps from African-Americans.

Authors:  Mehdi Nouraie; Fatemeh Hosseinkhah; Hassan Brim; Behrouz Zamanifekri; Duane T Smoot; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2010-03-12       Impact factor: 3.199

3.  A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.

Authors:  Olusegun Isaac Alatise; Omobolaji O Ayandipo; Ademola Adeyeye; Ken Seier; Akinwunmi O Komolafe; Matthew O Bojuwoye; Oludapo O Afuwape; Ann Zauber; Adeleye Omisore; Samuel Olatoke; Adegboyega Akere; Olusola Famurewa; Mithat Gonen; David O Irabor; T Peter Kingham
Journal:  Cancer       Date:  2018-04-12       Impact factor: 6.860

4.  Colon Capsule Endoscopy compared to Conventional Colonoscopy under routine screening conditions.

Authors:  Julia B Pilz; Susanne Portmann; Shajan Peter; Christoph Beglinger; Lukas Degen
Journal:  BMC Gastroenterol       Date:  2010-06-18       Impact factor: 3.067

5.  CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategies.

Authors:  Meher K Prakash; Brian Lang; Henriette Heinrich; Piero V Valli; Peter Bauerfeind; Amnon Sonnenberg; Niko Beerenwinkel; Benjamin Misselwitz
Journal:  BMC Med Inform Decis Mak       Date:  2017-06-05       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.